Updated:
Orient Hontai Capital
Orient Hontai Capital: State-backed Chinese private equity firm bridging state media conglomerates and global assets since 2014.
Orient Hontai Capital
Orient Hontai Capital is a private equity firm associated with Orient Security. It has made 8 investments, including a Series C investment in XWPharma on September 17, 2020. The firm has 2 portfolio exits, with AppLovin being its latest exit on April 15, 2021.
General information
Firm type
Private Equity
Year founded
2014
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Additional offices
Shanghai · Shenzhen
Sector focus
Frequently asked questions
Who backs Orient Hontai Capital?
Orient Hontai Capital is closely tied to China Media Capital (CMC) and Shanghai Media Group, two of the most influential state-backed media and entertainment conglomerates in China. This backing provided the firm with its initial capital and deal flow in Hollywood and European content assets. The exact LP base has never been publicly disclosed.
What was Orient Hontai's role in the Paramount Pictures deal?
In 2016, Orient Hontai Capital was the lead investor in a structured deal to acquire a strategic stake in Paramount Pictures, the storied Hollywood studio. The transaction was part of a broader wave of Chinese media capital entering the US entertainment industry. The deal did not result in a full buyout; Viacom, Paramount's parent, ultimately pursued a different path.
Is Orient Hontai Capital a state-owned enterprise?
Orient Hontai does not present itself as a direct state-owned enterprise but operates as a market-facing private equity firm with state institutional backing. Its founding ties to Shanghai Media Group and China Media Capital place it within the ecosystem of state-influenced capital, but its deal-making structure and fee model resemble a traditional private equity fund.
Does Orient Hontai invest outside of media and entertainment?
Yes. While media and entertainment deals — including the Paramount bid and Hollywood talent-agency outreach — generated its public profile, Orient Hontai has executed transactions in healthcare services, medical devices, and consumer brands. Its unifying thesis targets assets where Chinese market access materially alters growth trajectories.
How has Chinese regulatory policy affected Orient Hontai's investment activity?
China's 2017–2018 regulatory crackdown on 'irrational' outbound investment into entertainment, sports, and real estate hit Orient Hontai's core media deal flow. The firm significantly reduced its visible US media deal activity after that period, consistent with the broader shift in Beijing's capital-control and industrial-policy priorities. Its current activity is less publicly documented.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: